Understanding how firms build their capabilities, such as managerial skills, technology adoption and innovation capacity, is important for explaining why some firms perform better and how others can ...
Read the original version in Chinese here. FTA Group (FTA Group GmbH) entered China in 2003, with its headquarters in Shanghai. FTA focuses on the design of offices and industrial innovation districts ...
Duty-free giant Avolta said it is buying the business of rival DFS in Okinawa, Japan, entering the East Asian country for the first time. The deal covers DFS's operations at Okinawa's Naha Airport and ...
The PGA TOUR heads to one of golf’s ultimate survival tests as the U.S. Open returns to historic Shinnecock Hills Golf Club. With a 156-player field, a brutal top-60-and-ties cut line, and conditions ...
Barring a legal or regulatory miracle, the launch of a regulated iGaming market in Alberta will likely deal a serious blow to paid daily fantasy sports contests in the province. Alberta’s new ...
LOUISVILLE, Ky. — The sixth race at Del Mar on a random Saturday last July should not have been memorable in any way. Running for an $81,000 purse, a 4-year-old Thoroughbred named Nanci Griffith won ...
Friday's Major League Baseball schedule features 14 games, beginning at 6:40 p.m. ET, with the last first pitch set for 10:15 p.m. ET. There are a number of high-quality options in the MLB DFS player ...
ESPN's fantasy basketball daily cheat sheet is your pregame destination before you set your lineups for that night's games. Here you'll read our best advice for the night, including a selection of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...
Forbes contributors publish independent expert analyses and insights. Kevin covers retail, airports, and the global traveling shopper. The last U.S. vestiges of DFS Group—majority owned by luxury ...
SAN FRANCISCO -- The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease-free survival (DFS) in patients with clear cell renal cell carcinoma ...